Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral risperidone + clonazepam versus intramuscular haloperidol for psychomotor agitation due to psychosis
RBR-8s8tz32Phase 3Completed
- Sponsor
- Universidade Federal do Tocantins
- Start
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of risperidone, clonazepam and haloperidol in psychomotor agitation, Schizophrenia Spectrum Disorders (SSD) and bipolar disorder (BD), sponsored by Universidade Federal do Tocantins. Started Dec 2023; status: completed.
02
Drugs
risperidoneclonazepamhaloperidol
03
Conditions
psychomotor agitationSchizophrenia Spectrum Disorders (SSD)bipolar disorder (BD)
Beyond the preview
Go deeper on RBR-8s8tz32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-8s8tz32.